NEVRO CORP (NVRO)

Notable Wednesday Option Activity: COIN, NVRO, PRGO

Nevro to Present at BofA Securities 2024 Healthcare Conference

/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...

NVRO Stock Earnings: Nevro Beats EPS, Beats Revenue for Q1 2024

NVRO stock results show that Nevro beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

NVRO Stock Earnings: Nevro Beats EPS, Beats Revenue for Q1 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Nevro (NYSE:NVRO) just reported results for the first quarter of 2024.Nevro rep...

Oversold Conditions For Nevro

Non-Opioid Revolution: Beacons of Hope in Opioid Crisis and a $50 Million Spin-Off

Commit To Buy Nevro At $5, Earn 8.9% Annualized Using Options

FDA clears Nevro SI joint device without need for lateral screw (NYSE:NVRO)

Nevro (NVRO) said the FDA has cleared its sacroiliac joint fusion device for marketing without the need to include the lateral screw. Read more here.

Nevro Receives FDA 510(k) Clearance to Use SI Fixation System Without Need to Include Lateral Screw

/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company delivering comprehensive, life-changing solutions for the treatment of chronic pain,...

Noteworthy Monday Option Activity: NVRO, ALT, FRPT

Why Nevro Stock Lagged the Market on Thursday

Despite convincing beats on its latest set of quarterly figures, the market wasn't all that impressed with the company's latest developments.

Oppenheimer cuts Nevro to perform, cites weakness in core business (NYSE:NVRO)

Oppenheimer has downgraded Nevro (NVRO) to perform, citing continued weakness in its core spinal cord stimulation, or SCS, business. Read more here.

Nevro Enters Into Cooperation Agreement With Engaged Capital

/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...

Nevro Reports Fourth-Quarter and Full-Year 2023 Financial Results

/PRNewswire/ --Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic...

Engaged Capital adds Nevro, PRA Group; exits Primo Water (NASDAQ:UPBD)

Engaged Capital, a hedge fund, reveals its new stakes and increased positions in various companies, while reducing its holding in another.

Nevro Enters Oversold Territory (NVRO)

Nevro Announces Consensus Statement Supporting High-Frequency (10 kHz) Spinal Cord Stimulation Therapy for Refractory Painful Diabetic Neuropathy

/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...

Nevro to Report Fourth-Quarter and Full-Year 2023 Financial Results and Host Conference Call on February 21, 2024

/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...

Nevro Announces Positive Coverage Update from Carelon Healthcare for the Treatment of Painful Diabetic Neuropathy

/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...

Nevro to Highlight 25 Scientific Abstracts at 2024 North American Neuromodulation Society (NANS) Annual Meeting

/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company delivering comprehensive, life-changing solutions for the treatment of chronic pain,...

RBC downgrades Nevro to sector perform, cites salesforce turnaround (OTCMKTS:ENTBF)

RBC Capital Markets lowered its rating on Nevro (NVRO) to sector perform, commenting that the company's transition may take longer than planned. The investment

Nevro to lay off 5% of workforce, reports Q4 worldwide revenue of $116 million (NYSE:NVRO)

Nevro Corp plans to lay off 5% of its workforce by Q1 2024, expecting a positive impact on 2024 adjusted EBITDA.

Nevro to Present at 42nd Annual J.P. Morgan Healthcare Conference

/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...

Canaccord cuts Nevro to hold, citing increased competition (NYSE:NVRO)

Canaccord Genuity downgrades Nevro (NVRO) to hold, citing increased competition in the spinal cord stimulation market. Read more here.

Nevro stock gains after activist Engaged discloses stake (

Activist investor Engaged Capital discloses a stake in Nevro Corp., causing the company's shares to rise 7.8%.

Notable Friday Option Activity: NVRO, AMD, DLTR

Nevro acquires medical technology company Vyrsa Technologies (NYSE:NVRO)

Nevro acquires Vyrsa Technologies to enhance their medical technology solutions, with shares rising 1.6%.

Nevro Announces Acquisition of Vyrsa™ Technologies

/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...

Nevro Delivers Long-Term Relief with High-Frequency Spinal Cord Stimulation: 24-Month Data Demonstrates Profound Improvements for Non-Surgical Refractory Back Pain

/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...

Nevro GAAP EPS of -$0.65 beats by $0.12, revenue of $103.9M beats by $8.02M (NYSE:NVRO)

Nevro press release (NYSE:NVRO): Q3 GAAP EPS of -$0.65 beats by $0.12.Revenue of $103.9M (+3.4% Y/Y) beats by $8.02M.Expects fourth quarter of 2023...

Nevro Reports Third Quarter 2023 Financial Results, Provides Fourth Quarter Guidance and Updates Full-Year 2023 Guidance

/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...